ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 218 filers reported holding ACCELERON PHARMA INC in Q1 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $4,759,000 | -79.4% | 37,200 | -81.9% | 0.01% | -78.3% |
Q3 2020 | $23,092,000 | +78.7% | 205,207 | +51.3% | 0.02% | +109.1% |
Q2 2020 | $12,919,000 | -28.0% | 135,600 | -32.1% | 0.01% | -35.3% |
Q1 2020 | $17,938,000 | +760.3% | 199,600 | +246.5% | 0.02% | +325.0% |
Q3 2016 | $2,085,000 | +2.5% | 57,600 | -10.4% | 0.00% | -20.0% |
Q2 2015 | $2,034,000 | – | 64,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co IV LLC | 3,133,234 | $124,076,000 | 82.43% |
Deer VII & Co. Ltd. | 1,105,964 | $39,417,000 | 9.51% |
Foresite Capital Management I, LLC | 66,000 | $2,614,000 | 2.54% |
QVT Financial LP | 556,574 | $21,592,000 | 1.27% |
Orbimed Advisors | 2,117,648 | $83,859,000 | 1.23% |
SPHERA FUNDS MANAGEMENT LTD. | 50,000 | $1,980,000 | 0.55% |
WALL STREET ASSOCIATES | 93,800 | $3,714,000 | 0.30% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 197,219 | $7,810,000 | 0.28% |
EAM Investors, LLC | 37,871 | $1,500,000 | 0.27% |
Granite Point Capital Management, L.P. | 30,000 | $1,188,000 | 0.20% |